OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th
OraSure (NASDAQ: OSUR) will report fourth quarter 2025 financial results and host an earnings conference call on February 25, 2026 at 5:00 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OraSure (NASDAQ: OSUR) will report fourth quarter 2025 financial results and host an earnings conference call on February 25, 2026 at 5:00 PM ET. A live webcast will be available via the company's investor relations page and will be archived after the call.
Investors are asked to register and access the webcast at least 10 minutes before the start time.
Details
News Market Reaction – OSUR
On Feb 10, the first trading day after this news, OSUR closed 0.35% below the previous close.
Data tracked by StockTitan Argus for the Feb 10 session.
Key Figures
- Q3 2025 net revenues
- $27.085M
- Quarterly revenue, down 32% year over year
- Q3 2025 gross margin
- 43.5%
- Quarterly gross margin, slightly above prior year
- Q3 2025 operating loss
- $16.1M
- Quarterly operating loss reported in 10-Q
- Q3 2025 net loss
- $13.712M
- Quarterly net loss reported in 10-Q
- 9M 2025 net revenues
- $88.258M
- Nine-month revenues, down 41% year over year
- 9M 2025 operating loss
- $51.866M
- Nine-month operating loss in 10-Q
- Cash balance
- $216.478M
- Cash and equivalents as of Sept 30, 2025
- BioMedomics upfront payment
- $4.0M
- Cash consideration to acquire BioMedomics
Historical Context
-
Altai Capital nominates two directors amid concerns over share performance and strategy.
-
FDA submissions for CT/NG molecular self-test and Colli-Pee™ STI collection device.
-
Company responds to Altai, emphasizing $216M cash, no debt, buyback authorization.
-
Altai signals plan to nominate directors seeking governance and strategic changes.
-
Participation in Stephens conference with a webcasted Q&A session for investors.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BETHLEHEM, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2025 financial results and certain business developments for 5 p.m. ET on February 25, 2026.
A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended.
About OraSure Technologies, Inc.
OraSure Technologies, Inc. (“OraSure” and “OTI”) transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. OTI improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. Together with its wholly-owned subsidiaries, DNA Genotek Inc., Sherlock Biosciences, Inc., and BioMedomics, Inc., OTI is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OTI’s portfolio of products is sold globally to clinical laboratories, hospitals, physicians’ offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information, please visit www.orasure.com
| Investor Contact: Jason Plagman VP, Investor Relations investorinfo@orasure.com | Media Contact: Amy Koch Director, Corporate Communications media@orasure.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.